Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Amvis Holdings, Inc. 7071.T | 41 | Elevated | Healthcare | Japan | 5 / 6 | $256M |
| Clover Biopharmaceuticals, Ltd. 2197.HK | 72 | Stretched | Healthcare | China | 5 / 6 | $255M |
| Orasure Technologies Inc OSUR | 62 | Stretched | Healthcare | United States | 6 / 6 | $254M |
| Treace Medical Concepts Inc TMCI | 69 | Stretched | Healthcare | United States | 5 / 6 | $253M |
| Abeona Therapeutics Inc ABEO | 60 | Stretched | Healthcare | United States | 5 / 6 | $252M |
| Standard BioTools Inc LAB | 57 | Elevated | Healthcare | United States | 5 / 6 | $251M |
| Aurora Cannabis Inc ACB | 60 | Stretched | Healthcare | Canada | 5 / 6 | $251M |
| Medikit Co.,Ltd. 7749.T | 33 | Normal | Healthcare | Japan | 5 / 6 | $249M |
| Vanda Pharmaceuticals Inc VNDA | 63 | Stretched | Healthcare | United States | 6 / 6 | $247M |
| Biodesix Inc BDSX | 53 | Elevated | Healthcare | United States | 6 / 6 | $247M |
| AIM Vaccine Co., Ltd. 6660.HK | 74 | Stretched | Healthcare | China | 5 / 6 | $246M |
| Echoiq Ltd EIQ | 95 | Acute | Healthcare | Australia | 3 / 6 | $246M |
| Daito Pharmaceutical Co., Ltd. 4577.T | 36 | Normal | Healthcare | Japan | 5 / 6 | $245M |
| Jacobson Pharma Corporation Limited 2633.HK | 31 | Normal | Healthcare | Hong Kong | 5 / 6 | $245M |
| INC Research Holdings Inc INCR | 45 | Elevated | Healthcare | Israel | 5 / 6 | $244M |
| CPBIO Holding Company Limited 3839.HK | 23 | Normal | Healthcare | Hong Kong | 5 / 6 | $242M |
| Amarin Corp AMRN | 73 | Stretched | Healthcare | Ireland | 4 / 6 | $242M |
| Lifecore Biomedical Inc LFCR | 72 | Stretched | Healthcare | United States | 5 / 6 | $241M |
| Antengene Corporation Limited 6996.HK | 58 | Elevated | Healthcare | China | 5 / 6 | $240M |
| Lineage Cell Therapeutics Inc LCTX | 64 | Stretched | Healthcare | United States | 4 / 6 | $240M |
| Healios K.K. 4593.T | 63 | Stretched | Healthcare | Japan | 5 / 6 | $240M |
| Quantum-Si Incorporated - Class A QSI | 49 | Elevated | Healthcare | United States | 5 / 6 | $239M |
| Utah Medical Products Inc UTMD | 54 | Elevated | Healthcare | United States | 6 / 6 | $237M |
| Shandong Boan Biotechnology Co., Ltd. 6955.HK | 45 | Elevated | Healthcare | China | 5 / 6 | $237M |
| High Tide Inc HITI | 41 | Elevated | Healthcare | Canada | 5 / 6 | $233M |
| Acotec Scientific Holdings Limited 6669.HK | 20 | Normal | Healthcare | China | 5 / 6 | $232M |
| Ascom Holding AG ASCN | 51 | Elevated | Healthcare | Switzerland | 4 / 6 | $232M |
| Electromed Inc ELMD | 33 | Normal | Healthcare | United States | 4 / 6 | $229M |
| Valerio Therapeutics ALVIO | 48 | Elevated | Healthcare | France | 5 / 6 | $229M |
| BioAge Labs Inc BIOA | 77 | Stretched | Healthcare | United States | 5 / 6 | $228M |
| Sinohealth Technology Holdings Limited 2361.HK | 38 | Normal | Healthcare | China | 5 / 6 | $227M |
| Diaceutics PLC DXRX | 28 | Normal | Healthcare | United Kingdom | 5 / 6 | $226M |
| Mediantechn ALMDT | 71 | Stretched | Healthcare | France | 5 / 6 | $226M |
| SIGA Technologies Inc SIGA | 56 | Elevated | Healthcare | United States | 6 / 6 | $226M |
| Tetratherix Ltd TTX | 69 | Stretched | Healthcare | Australia | 4 / 6 | $225M |
| ASCOM HLDG NA SF 0,50 AH2N | 51 | Elevated | Healthcare | Switzerland | 4 / 6 | $223M |
| AC Immune SA ACIU | 75 | Stretched | Healthcare | Switzerland | 5 / 6 | $222M |
| Koa Shoji Holdings Co.,Ltd. 9273.T | 22 | Normal | Healthcare | Japan | 4 / 6 | $220M |
| Keros Therapeutics Inc KROS | 9 | Contained | Healthcare | United States | 5 / 6 | $219M |
| TRANSGENE TNG.PA | 65 | Stretched | Healthcare | France | 5 / 6 | $218M |
| Spok Holdings Inc SPOK | 58 | Elevated | Healthcare | United States | 5 / 6 | $218M |
| Alector Inc ALEC | 71 | Stretched | Healthcare | United States | 5 / 6 | $218M |
| WIN-Partners Co., Ltd. 3183.T | 35 | Normal | Healthcare | Japan | 5 / 6 | $217M |
| Fate Therapeutics Inc FATE | 80 | Acute | Healthcare | United States | 5 / 6 | $217M |
| TriSalus Life Sciences Inc TLSI | 53 | Elevated | Healthcare | United States | 5 / 6 | $217M |
| Atrys Health SL ATRY | 71 | Stretched | Healthcare | Spain | 5 / 6 | $216M |
| Profound Medical Corp PROF | 45 | Elevated | Healthcare | Canada | 6 / 6 | $214M |
| InflaRx N.V. IFRX | 69 | Stretched | Healthcare | Germany | 5 / 6 | $214M |
| Sol-Gel Technologies Ltd SLGL | 29 | Normal | Healthcare | Israel | 5 / 6 | $213M |
| Guangzhou Innogen Pharmaceutical Group Co., Ltd 2591.HK | 69 | Stretched | Healthcare | China | 4 / 6 | $212M |
| Macrogenics Inc MGNX | 67 | Stretched | Healthcare | United States | 5 / 6 | $212M |
| Chaoju Eye Care Holdings Limited 2219.HK | 23 | Normal | Healthcare | China | 5 / 6 | $211M |
| Mizuho Medy Co.,Ltd. 4595.T | 51 | Elevated | Healthcare | Japan | 4 / 6 | $211M |
| American Well Corporation - Class A AMWL | 61 | Stretched | Healthcare | United States | 6 / 6 | $209M |
| Protalix BioTherapeutics Inc PLX | 53 | Elevated | Healthcare | United States | 5 / 6 | $206M |
| Lyell Immunopharma Inc LYEL | 68 | Stretched | Healthcare | United States | 4 / 6 | $206M |
| Mega Genomics Limited 6667.HK | 36 | Normal | Healthcare | China | 5 / 6 | $203M |
| Newron Pharmaceuticals S.p.A. NWRN.SW | 47 | Elevated | Healthcare | Italy | 5 / 6 | $202M |
| Monash Ivf Group Ltd MVF | 54 | Elevated | Healthcare | Australia | 4 / 6 | $200M |
| Seikagaku Corporation 4548.T | 52 | Elevated | Healthcare | Japan | 5 / 6 | $200M |
| Japan Tissue Engineering Co., Ltd. 7774.T | 70 | Stretched | Healthcare | Japan | 4 / 6 | $199M |
| eWeLL Co.,Ltd. 5038.T | 13 | Contained | Healthcare | Japan | 4 / 6 | $199M |
| Thor Medical ASA TRMED | 66 | Stretched | Healthcare | Norway | 3 / 6 | $199M |
| MTI Ltd. 9438.T | 31 | Normal | Healthcare | Japan | 5 / 6 | $196M |
| NEWRON PHARMACEUT. EO-20 NP5 | 47 | Elevated | Healthcare | Italy | 5 / 6 | $196M |
| RxSight Inc RXST | 45 | Elevated | Healthcare | United States | 6 / 6 | $195M |
| So-Young International Inc SY | 68 | Stretched | Healthcare | China | 5 / 6 | $191M |
| Evommune Inc EVMN | 48 | Elevated | Healthcare | United States | 5 / 6 | $191M |
| Healius Limited HLS.AX | 68 | Stretched | Healthcare | Australia | 4 / 6 | $190M |
| Limes Schlosskliniken AG LIK | 14 | Contained | Healthcare | Germany | 5 / 6 | $189M |
| Beijing Biostar Pharmaceuticals Co., Ltd. 2563.HK | 63 | Stretched | Healthcare | China | 5 / 6 | $189M |
| Entrada Therapeutics Inc TRDA | 64 | Stretched | Healthcare | United States | 5 / 6 | $188M |
| Sutro Biopharma Inc STRO | 61 | Stretched | Healthcare | United States | 4 / 6 | $187M |
| Compugen Ltd CGEN | 13 | Contained | Healthcare | Israel | 5 / 6 | $187M |
| Wuhan Dazhong Dental Medical Co., Ltd. 2651.HK | 37 | Normal | Healthcare | China | 5 / 6 | $186M |
| Alpha Cognition Inc ACOG | 83 | Acute | Healthcare | United States | 4 / 6 | $185M |
| Q32 Bio Inc QTTB | 23 | Normal | Healthcare | United States | 4 / 6 | $185M |
| ProQR Therapeutics N.V PRQR | 53 | Elevated | Healthcare | Netherlands | 5 / 6 | $185M |
| Akebia Therapeutics Inc AKBA | 40 | Elevated | Healthcare | United States | 6 / 6 | $185M |
| AOTI Inc AOTI | 34 | Normal | Healthcare | United States | 5 / 6 | $184M |
| Pro-Dex Inc (co) PDEX | 29 | Normal | Healthcare | United States | 5 / 6 | $184M |
| Adc Therapeutics SA ADCT | 62 | Stretched | Healthcare | Switzerland | 6 / 6 | $184M |
| Cartesian Therapeutics Inc RNAC | 68 | Stretched | Healthcare | United States | 4 / 6 | $183M |
| Bioversys AG BIOV | 66 | Stretched | Healthcare | Switzerland | 4 / 6 | $182M |
| Distinct Healthcare Holdings Limited 2677.HK | 27 | Normal | Healthcare | China | 5 / 6 | $181M |
| Dawnrays Pharmaceutical (Holdings) Limited 2348.HK | 43 | Elevated | Healthcare | Hong Kong | 5 / 6 | $180M |
| Invivyd Inc IVVD | 48 | Elevated | Healthcare | United States | 5 / 6 | $180M |
| Exagen Inc XGN | 48 | Elevated | Healthcare | United States | 6 / 6 | $180M |
| Golden Throat Holdings Group Company Limited 6896.HK | 37 | Normal | Healthcare | China | 5 / 6 | $179M |
| Saint Bella Group Limited 2508.HK | 27 | Normal | Healthcare | China | 5 / 6 | $178M |
| Bicycle Therapeutics Plc BCYC | 42 | Elevated | Healthcare | United Kingdom | 5 / 6 | $178M |
| Kusurinomadoguchi, Inc. 5592.T | 17 | Contained | Healthcare | Japan | 5 / 6 | $177M |
| Jilin Province Huinan Changlong Bio-pharmacy Company Limited 8049.HK | 25 | Normal | Healthcare | Hong Kong | 5 / 6 | $177M |
| Rici Healthcare Holdings Limited 1526.HK | 28 | Normal | Healthcare | China | 5 / 6 | $177M |
| Inogen Inc INGN | 50 | Elevated | Healthcare | United States | 6 / 6 | $175M |
| CE Holdings Co.,Ltd. 4320.T | 43 | Elevated | Healthcare | Japan | 5 / 6 | $172M |
| EUCALIA Inc. 286A.T | 38 | Normal | Healthcare | Japan | 5 / 6 | $172M |
| Whitehawk Therapeutics Inc WHWK | 74 | Stretched | Healthcare | United States | 6 / 6 | $172M |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. R9Z | 43 | Elevated | Healthcare | China | 5 / 6 | $171M |
| FALCO HOLDINGS Co., Ltd. 4671.T | 36 | Normal | Healthcare | Japan | 5 / 6 | $171M |
By sector
Industrials 3,117Technology 2,425Consumer Cyclical 2,231Healthcare 1,695Consumer Defensive 1,055Basic Materials 1,055Real Estate 1,011Communication Services 956Energy 487Utilities 343Financial Services 90
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.